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Background
Many of the positive adaptations resulting from resistance
exercise training (i.e., increased muscle mass and strength,
decreased fat mass) are thought to be mediated, in part, by
exercise-induced increases in growth hormone (GH). One
ingredient that has shown clinical promise in elevating
GH is the acetylcholine precursor alpha-glycerylphospho-
rylcholine (A-GPC). The purpose of this study was to
examine the effects of a supplement containing primarily
A-GPC on serum GH levels, explosive performance, and
post-exercise substrate oxidation.
Methods
Using a randomized, placebo-controlled, crossover
design, seven men (mean ± SD age, height, weight, body
fat: 30.1 ± 7.3 y, 179.2 ± 7.4 cm, 87.3 ± 11.6 kg, 18.1 ±
5.9%) with at least two years of resistance training experi-
ence ingested 600 mg A-GPC (as AlphaSize™) or a placebo
90-minutes prior to completing 6 sets × 10 repetitions of
Smith Machine squats at 70% of their pre-determined 1-
repetition maximum. At 30-minutes post-exercise, resting
metabolic rate (RMR) and respiratory exchange ratio
(RER) were measured with indirect calorimetry to assess
post-exercise caloric expenditure and carbohydrate and fat
oxidation, respectively. Immediately following RMR and
RER measurements, subjects performed three sets of
bench press throws at 50% of their pre-determined 1-rep-
etition maximum to assess peak force, peak power, and
rate of force development. All trials were performed after
an overnight fast, a 48-hour abstention from intense exer-
cise, and during the same time of day to minimize diurnal
variation. Serum samples were obtained prior to exercise
and again 0, 5, 15, 30, 60, 90 and 120 minutes post-exer-
cise. Hormone concentrations were analyzed in duplicate
by Quest Diagnostics® via immunoassay. Statistical evalu-
ation of the data was accomplished using dependent t-
tests (peak force, peak power, rate of force development)
and repeated measures ANOVA (GH, RMR, RER). Differ-
ences were considered "significant" at P ≤ 0.05.
Results
Compared to baseline (pre) values, peak GH increased
44-fold during A-GPC (from 0.19 ± 0.06 to 8.4 ± 2.1 ng/
mL) vs. 2.6-fold during placebo (from 1.9 ± 0.8 to 5.0 ±
4.8 ng/mL, P < 0.03) (Figure 1). Peak bench press force
was 14% greater in A-GPC (933 ± 89 N) vs. placebo (818
± 77 N, P < 0.02). Trends toward higher peak bench press
power (P < 0.13) and lower post-exercise RER (P < 0.12)
were noted in the A-GPC trial.
Conclusion
These data indicate that a single 600 mg dose of A-GPC (as
AlphaSize™), when administered 90 minutes prior to
resistance exercise, increases post-exercise serum GH and
peak bench press force. In contrast, A-GPC had no statis-
tically significant effect on peak power, rate of force devel-
opment, RMR, or cardiovascular hemodynamics (i.e.,
heart rate and blood pressure). Future work should exam-
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ine how resistance exercise + A-GPC affect the GH-IGF axis
and their associated family of binding proteins.
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